Literature DB >> 11054259

Apparent founder effect during the early years of the San Francisco HIV type 1 epidemic (1978-1979).

B Foley1, H Pan, S Buchbinder, E L Delwart.   

Abstract

HIV-1 envelope sequence variants were RT-PCR amplified from serum samples cryopreserved in San Francisco in 1978-1979. The HIV-1 subtype B env V3-V5 sequences from four homosexual men clustered phylogenetically, with a median nucleotide distance of 2.8%, reflecting a recent common origin. These early U.S. HIV-1 env variants mapped close to the phylogenetic root of the subtype B tree while env variants collected in the United States throughout the 1980s and 1990s showed, on average, increasing genetic diversity and divergence from the subtype B consensus sequence. These results indicate that the majority of HIV-1 currently circulating in the United States may be descended from an initial introduction and rapid spread during the mid- to late 1970s of subtype B viruses with limited variability (i.e., a founder effect). As expected from the starburst-shaped phylogeny of HIV-1 subtype B, contemporary U.S. strains were, on average, more closely related at the nucleic acid and amino acid levels to the earlier 1978-1979 env variants than to each other. The growing levels of HIV-1 genetic diversity, one of multiple obstacles in designing a protective vaccine, may therefore be mitigated by using epidemic founding variants as antigenic strains for protection against contemporary strains.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11054259     DOI: 10.1089/088922200750005985

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  14 in total

1.  Analysis of HIV type 1 BF recombinant sequences from South America dates the origin of CRF12_BF to a recombination event in the 1970s.

Authors:  Dario A Dilernia; Leandro R Jones; Maria A Pando; Roberto D Rabinovich; Gabriel D Damilano; Gabriela Turk; Andrea E Rubio; Sandra Pampuro; Manuel Gomez-Carrillo; Horacio Salomón
Journal:  AIDS Res Hum Retroviruses       Date:  2010-12-03       Impact factor: 2.205

2.  Population-Level Immune-Mediated Adaptation in HIV-1 Polymerase during the North American Epidemic.

Authors:  Natalie N Kinloch; Daniel R MacMillan; Anh Q Le; Laura A Cotton; David R Bangsberg; Susan Buchbinder; Mary Carrington; Jonathan Fuchs; P Richard Harrigan; Beryl Koblin; Margot Kushel; Martin Markowitz; Kenneth Mayer; M J Milloy; Martin T Schechter; Theresa Wagner; Bruce D Walker; Jonathan M Carlson; Art F Y Poon; Zabrina L Brumme
Journal:  J Virol       Date:  2015-11-11       Impact factor: 5.103

3.  Early evolution of the human immunodeficiency virus type 1 subtype C epidemic in rural Malawi.

Authors:  Grace P McCormack; Judith R Glynn; Amelia C Crampin; Felix Sibande; Dominic Mulawa; Lyn Bliss; Philip Broadbent; Katia Abarca; Jorg M Pönnighaus; Paul E M Fine; Jonathan P Clewley
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

4.  1970s and 'Patient 0' HIV-1 genomes illuminate early HIV/AIDS history in North America.

Authors:  Michael Worobey; Thomas D Watts; Richard A McKay; Marc A Suchard; Timothy Granade; Dirk E Teuwen; Beryl A Koblin; Walid Heneine; Philippe Lemey; Harold W Jaffe
Journal:  Nature       Date:  2016-10-26       Impact factor: 49.962

5.  Sequencing-based detection of low-frequency human immunodeficiency virus type 1 drug-resistant mutants by an RNA/DNA heteroduplex generator-tracking assay.

Authors:  Amit Kapoor; Morris Jones; R W Shafer; Soo-Yon Rhee; Powel Kazanjian; Eric L Delwart
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

6.  Human immunodeficiency virus type 1 superinfection was not detected following 215 years of injection drug user exposure.

Authors:  Rose Tsui; Belinda L Herring; Jason D Barbour; Robert M Grant; Peter Bacchetti; Alex Kral; Brian R Edlin; Eric L Delwart
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

7.  U.S. Human immunodeficiency virus type 1 epidemic: date of origin, population history, and characterization of early strains.

Authors:  Kenneth E Robbins; Philippe Lemey; Oliver G Pybus; Harold W Jaffe; Ae S Youngpairoj; Teresa M Brown; Marco Salemi; Anne-Mieke Vandamme; Marcia L Kalish
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

8.  Segregation of human immunodeficiency virus type 1 subtypes by risk factor in Australia.

Authors:  Belinda L Herring; Ying C Ge; Bin Wang; Mala Ratnamohan; Frank Zheng; Anthony L Cunningham; Nitin K Saksena; Dominic E Dwyer
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

9.  The predominance of Human Immunodeficiency Virus type 1 (HIV-1) circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitness.

Authors:  Harr F Njai; Youssef Gali; Guido Vanham; Claude Clybergh; Wim Jennes; Nicole Vidal; Christelle Butel; Eitel Mpoudi-Ngolle; Martine Peeters; Kevin K Ariën
Journal:  Retrovirology       Date:  2006-07-03       Impact factor: 4.602

10.  Genotypic and functional impact of HIV-1 adaptation to its host population during the North American epidemic.

Authors:  Laura A Cotton; Xiaomei T Kuang; Anh Q Le; Jonathan M Carlson; Benjamin Chan; Denis R Chopera; Chanson J Brumme; Tristan J Markle; Eric Martin; Aniqa Shahid; Gursev Anmole; Philip Mwimanzi; Pauline Nassab; Kali A Penney; Manal A Rahman; M-J Milloy; Martin T Schechter; Martin Markowitz; Mary Carrington; Bruce D Walker; Theresa Wagner; Susan Buchbinder; Jonathan Fuchs; Beryl Koblin; Kenneth H Mayer; P Richard Harrigan; Mark A Brockman; Art F Y Poon; Zabrina L Brumme
Journal:  PLoS Genet       Date:  2014-04-24       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.